scholarly article | Q13442814 |
P356 | DOI | 10.1002/ANIE.201409678 |
P698 | PubMed publication ID | 25483297 |
P50 | author | Maria Luisa Gelmi | Q57237393 |
Peta J Harvey | Q57306980 | ||
Richard J. Lewis | Q40373224 | ||
Alessandro Gori | Q41718756 | ||
P2093 | author name string | Renato Longhi | |
Andreas Brust | |||
K Johan Rosengren | |||
Paul F Alewood | |||
Macdonald J Christie | |||
Rebecca F Bhola | |||
Ching-I A Wang | |||
P2860 | cites work | Solving the alpha-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonists. | Q43159292 |
chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain | Q43254107 | ||
Engineering and functionalization of the disulfide-constrained miniprotein min-23 as a scaffold for diagnostic application | Q45107054 | ||
Disulfide bonds, their stereospecific environment and conservation in protein structures | Q45171411 | ||
Isolation, characterization and total regioselective synthesis of the novel μO-conotoxin MfVIA from Conus magnificus that targets voltage-gated sodium channels | Q45805820 | ||
Maintaining biological activity by using triazoles as disulfide bond mimetics | Q46116432 | ||
Structure and activity of (2,8)-dicarba-(3,12)-cystino alpha-ImI, an alpha-conotoxin containing a nonreducible cystine analogue | Q46173962 | ||
Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. | Q46762144 | ||
Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists | Q46962955 | ||
Cyclization of peptides by using selenolanthionine bridges. | Q54210515 | ||
Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain | Q58284514 | ||
Total Synthesis of Human Hepcidin through Regioselective Disulfide-Bond Formation by using the Safety-Catch Cysteine Protecting Group 4,4′-Dimethylsulfinylbenzhydryl | Q58284530 | ||
Vicinal Disulfide Constrained Cyclic Peptidomimetics: a Turn Mimetic Scaffold Targeting the Norepinephrine Transporter | Q58284578 | ||
Conus venom peptide pharmacology | Q27003318 | ||
The Cyclic Cystine Ladder in -Defensins Is Important for Structure and Stability, but Not Antibacterial Activity | Q27676502 | ||
Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability | Q27756877 | ||
Solution structure of chi-conopeptide MrIA, a modulator of the human norepinephrine transporter | Q30991214 | ||
Combinatorial library of peptidotriazoles: identification of [1,2,3]-triazole inhibitors against a recombinant Leishmania mexicana cysteine protease | Q33202737 | ||
High-threshold mechanosensitive ion channels blocked by a novel conopeptide mediate pressure-evoked pain | Q33287466 | ||
Cu-catalyzed azide-alkyne cycloaddition | Q34807878 | ||
Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides | Q36981618 | ||
Kinetic and thermodynamic aspects of cellular thiol-disulfide redox regulation | Q37327551 | ||
Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics | Q37900558 | ||
Venoms as a platform for human drugs: translating toxins into therapeutics | Q37937049 | ||
Cysteine-rich mini-proteins in human biology. | Q38029087 | ||
Multifaceted roles of disulfide bonds. Peptides as therapeutics. | Q38180456 | ||
Discovery, synthesis, and structure-activity relationships of conotoxins. | Q38203598 | ||
Metabolism of neurohypophysial hormones | Q40846749 | ||
Oxidative folding of cystine-rich peptides vs regioselective cysteine pairing strategies | Q41094522 | ||
Disulfide-Depleted Selenoconopeptides: a Minimalist Strategy to Oxidative Folding of Cysteine-Rich Peptides | Q41853571 | ||
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs | Q41979383 | ||
Modulating oxytocin activity and plasma stability by disulfide bond engineering | Q42789969 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1361-1364 | |
P577 | publication date | 2014-12-05 | |
P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
P1476 | title | Stabilization of the cysteine-rich conotoxin MrIA by using a 1,2,3-triazole as a disulfide bond mimetic. | |
P478 | volume | 54 |